HRT Financial
PLYX icon

HRT Financial’s Polaryx Therapeutics Inc PLYX Stock Holding History

HRT Financial’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$68K Sell
33,103
-48,991
-60% -$107K ﹤0.01% 4247
2026
Q2 		$218K Buy
+82,094
New +$322K ﹤0.01% 3351

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $87.3B AUM 22.01% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $225B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

HRT Financial's PLYX Position: Q3 2026 in Review

HRT Financial reduced its Polaryx Therapeutics Inc (PLYX) stake by 60% in Q3 2026, selling an estimated $107K and leaving 33,103 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #4247.

HRT Financial first reported a position in PLYX in Q2 2026 and has held it in 2 quarters since. The position peaked at $218K in Q2 2026. 11 funds tracked by Wall St. Rank hold PLYX as of Q3 2026.

  • HRT Financial held 33,103 shares of Polaryx Therapeutics Inc worth $68K as of Q3 2026.
  • HRT Financial sold 48,991 Polaryx Therapeutics Inc shares in Q3 2026, an estimated $107K.
  • Polaryx Therapeutics Inc made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4247 holding.
  • HRT Financial first reported a position in Polaryx Therapeutics Inc in Q2 2026 and has held it in 2 quarters since.
  • HRT Financial's Polaryx Therapeutics Inc position peaked at $218K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.